Philip & Daniele Barach Family Trust - 23 Sep 2026 Form 4 Insider Report for Celularity Inc (CELU)

Reporting relationship: 10%+ Owner
Issuer ticker: CELU
Reported as of: 23 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 25 Sep 2026, 16:59:56 UTC
Prior SEC filing: 23 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Philip A. Barach, Trustee

Key filing fact

Philip & Daniele Barach Family Trust filed Form 4 for Celularity Inc (CELU) on 25 Sep 2026.

Key facts

This page summarizes Philip & Daniele Barach Family Trust's Form 4 filing for Celularity Inc (CELU).
5 reported transactions and 7 derivative rows are listed below.
Accepted by SEC: 25 Sep 2026, 16:59.

Change

Previous filing in this sequence was filed on 23 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002107059 Primary reporting owner

Philip & Daniele Barach Family Trust

Relationship: 10%+ Owner
Address: 434 SURFVIEW DRIVE, PACIFIC PALISADES
Signature: /s/ Philip A. Barach, Trustee
Signature date: 24 Sep 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CELU transaction Derivative

Convertible Notes

Other

Transaction value
Shares: +192,771
Change %: +11%
Price
Shares after: 2,000,000
Date: 23 Sep 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 2,000,000
Exercise price: $1.50
Footnotes: F1

CELU transaction Derivative

Convertible Notes

Other

Transaction value
Shares: +2,140,000
Change %
Price
Shares after: 2,140,000
Date: 23 Sep 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 2,140,000
Exercise price: $1.50
Footnotes: F3

CELU transaction Derivative

Warrants

Other

Transaction value
Shares: +1,177,000
Change %
Price
Shares after: 1,177,000
Date: 23 Sep 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 1,177,000
Exercise price: $1.50
Footnotes: F3, F4

CELU transaction Derivative

Convertible Notes

Other

Transaction value
Shares: +1,457,765
Change %
Price
Shares after: 1,457,765
Date: 23 Sep 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 1,457,765
Exercise price: $2.00
Footnotes: F5

CELU transaction Derivative

Warrants

Other

Transaction value
Shares: +1,457,765
Change %
Price
Shares after: 1,457,765
Date: 23 Sep 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 1,457,765
Exercise price: $2.00
Footnotes: F5, F6

CELU holding Derivative

Warrants

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,258,740
Date: 23 Sep 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 1,258,740
Exercise price: $1.50
Footnotes: F2

CELU holding Derivative

Warrants

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,448,917
Date: 23 Sep 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 2,448,917
Exercise price: $2.00

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Represents the amendment and restatement on September 23, 2026 of an existing convertible note of the Issuer in which the applicable conversion price was reduced from $1.66 per share to $1.50 per share and the maturity date was extended from December 31, 2026 to September 23, 2028, as a result of which the number of shares issuable upon conversion of such note was increased from 1,807,229 to 2,000,000. No additional consideration was paid in connection with such amendment and restatement.

Footnote F2

Represents the amendment and restatement on September 23, 2026 of existing warrants of the Issuer in which exercise price of such warrants was reduced from $2.00 per share to $1.50 per share and the termination date of such warrants was extended to September 23, 2031. No additional consideration was paid in connection with such amendment and restatement.

Footnote F3

Represents shares of Class A Common Stock issuable upon the conversion of $3,210,000 in aggregate principal amount of convertible notes (the "September 2026 Notes") that the Reporting Person purchased from the Issuer for such an amount of cash on September 23, 2026.

Footnote F4

Represents shares of Class A Common Stock issuable upon the exercise of 1,177,000 warrants that the Reporting Person obtained from the Issuer in connection with the issuance of the September 2026 Notes. No additional consideration was paid in connection with the issuance of such warrants.

Footnote F5

Represents shares of Class A Common Stock issuable upon the conversion of up to $2,915,531 in aggregate principal amount of convertible notes (the "September 2027 Notes") that the Reporting Person has the option to purchase from the Issuer at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.

Footnote F6

Represents shares of Class A Common Stock issuable upon the exercise of up to 1,457,765 warrants that the Reporting Person has the option to obtain from the Issuer for in connection with the issuance of September 2027 Notes at any time until September 30, 2027. Such option is a contractual right granted by the Issuer in connection with the issuance of the September 2026 Notes for, which no additional consideration was paid.